Search results (46)
« Back to News & OpinionNews and Opinion from the Pandemic Sciences Institute at the University of Oxford
New research reveals optimal time intervals for COVID-19 vaccine boosters
1 September 2025
Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.
PSI-industry oral vaccine project aims to transform immunisation strategies
18 August 2025
The project led by Professor Dame Sarah Gilbert is one of the winners of the first VaxHub Sustainable Platform Funding Call.
Bubonic plague treatment proven highly effective and safe in global first
6 August 2025
Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague.
HRH The Duke of Gloucester visits University of Oxford’s cutting-edge vaccine facilities
25 July 2025
The visit to the Clinical BioManufacturing Facility and the laboratories of the Oxford Vaccine Group and Pandemic Sciences Institute showcased Oxford’s global leadership in medical science and innovation.
Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation
9 June 2025
The designation recognises the vaccine’s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.
New research published on maximising mpox vaccine availability
5 June 2025
Scientists have studied the immune response of a dose-sparing regimen to expand vaccine supply and protect more people from mpox.
Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research
8 April 2025
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.
RECOVERY trial team win NIHR Impact Prize
21 March 2025
Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.
New paper outlines ethical issues in clinical metagenomics
7 March 2025
This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
Advances in AI can help prepare the world for the next pandemic
19 February 2025
- Epidemiology & data
- Ethics, social science & humanities
- Pathogen biology & new threats
- Research news
- Vaccines, treatments, diagnostics & trials
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
New partnership to advance public health and life science research collaboration in West Africa
13 February 2025
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Study provides new insights into mpox clinical outcomes and transmission
16 January 2025
Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.
Pig research paves way for human respiratory vaccine development
9 January 2025
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
Study explores aerosol immunisation as path to broadly protective influenza vaccine
16 October 2024
Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.
Oxford Vaccine Group announces return of science and healthcare podcast
19 September 2024
A brand-new season of The Oxford Colloquy – a podcast series of conversations with leading experts in science and healthcare – is launched this week by Oxford Vaccine Group.
PSI collaborates with Oxford’s History of Science Museum on new exhibition
12 August 2024
The latest exhibition "A Healthy Future for All?" explores the science driving advancements in healthcare.
Oxford scientists launch first-in-human vaccine trial for deadly Marburg virus
12 July 2024
Launch of UK trial is major milestone in developing a vaccine against Marburg virus – a highly virulent disease that is fatal in up to 88% of cases.
Pandemic computer simulations to guide future vaccine trials
23 May 2024
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
Science Museum’s Injecting Hope exhibition enters final week
2 May 2024
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.